2012
Neoadjuvant chemoradiation and intraoperative electron irradiation for locally unresectable/borderline resectable pancreas adenocarcinoma.
Ashman J, Moss A, Callister M, Reddy K, Mulligan D, Gunderson L, Borad M. Neoadjuvant chemoradiation and intraoperative electron irradiation for locally unresectable/borderline resectable pancreas adenocarcinoma. Journal Of Clinical Oncology 2012, 30: 327-327. DOI: 10.1200/jco.2012.30.4_suppl.327.Peer-Reviewed Original ResearchIntraoperative electron irradiationOverall survivalNeoadjuvant chemotherapyNeoadjuvant therapyPancreas adenocarcinomaPancreatic cancerKaplan-Meier survival analysisThree-year OSAdvanced pancreatic cancerMedian overall survivalNovel systemic agentsLog-rank testCurative surgeryR1 patientsR1 resectionDistant diseaseLocal progressionNeoadjuvant chemoradiationPreoperative therapyMedian survivalResection statusSurgical resectionSystemic agentsComplete resectionLocal therapy
2006
Living donor liver transplantation for hepatitis C‐related cirrhosis: No difference in histological recurrence when compared to deceased donor liver transplantation recipients
Guo L, Orrego M, Rodriguez‐Luna H, Balan V, Byrne T, Chopra K, Douglas DD, Harrison E, Moss A, Reddy KS, Williams JW, Rakela J, Mulligan D, Vargas HE. Living donor liver transplantation for hepatitis C‐related cirrhosis: No difference in histological recurrence when compared to deceased donor liver transplantation recipients. Liver Transplantation 2006, 12: 560-565. PMID: 16555313, DOI: 10.1002/lt.20660.Peer-Reviewed Original ResearchConceptsDeceased donor liver transplantationDonor liver transplantationLiver transplantationHistological recurrenceHepatitis CDeceased-donor liver transplantation (DDLT) recipientsEnd-stage liver disease (MELD) scoreDonor liver transplantation recipientsHepatitis C virus infectionKaplan-Meier survival analysisDetectable HCV RNAHistological recurrence rateC virus infectionGraft survival ratesLiver Disease scoreActivity of inflammationLiver transplantation recipientsStatistical differenceChild-TurcotteDDLT groupLDLT patientsPugh scoreRecurrent HCVLiver transplantYears posttransplantation